The cholinergic hypothesis, one of the leading theories in Alzheimer’s disease (AD) pathogenesis, suggests that the inhibition of cholinesterase enzymes, particularly acetylcholinesterase (AChE), is a key therapeutic strategy to counteract the decline in acetylcholine levels in the brain. This evidence concerns the gene ACHE and Alzheimer disease.